Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the ...

Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks over ...

Pfizer (PFE) colorectal cancer therapy Braftovi as part of a drug combo indicates a favorable objective response rate in a ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant finding in cancer immunotherapy. The team discovered a unique population of immune cells ...

Joel Lambert, the Senior Vice President, General Counsel, and Secretary at Flowco Holdings Inc. (NASDAQ:FLOC), recently acquired 4,300 shares of the company's Class A ...

With a full-blown land war in Ukraine and an isolationist American president back in the White House, European leaders have come to a stark conclusion: They must spend more on their militaries ...